ChinaResearch and clinical trials
28 ASA patients in China: liver transplant corrected ammonia but did not prevent developmental delay
At a center in Shanghai, 28 patients with ASA followed between 2011 and 2024 were reviewed.
Inborn errors of metabolism
An inherited urea cycle disorder. The body cannot get rid of the nitrogen left over from protein. Ammonia builds up in the blood and can affect the brain.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
Orphanet has a guideline for emergency doctors for this disease (language: French). See on Orphanet
This page is translated from the Turkish original.
This disease is followed through the “Inborn errors of metabolism” group.
When the body uses protein, it makes a waste product called nitrogen. The liver turns this waste into urea and removes it in the urine. In this disease, an enzyme needed for this job is missing. Nitrogen builds up in the blood as ammonia. When there is too much ammonia, it harms the brain most of all.
The severe form often begins in the first days after birth. The mild form may appear later and come in attacks.
The levels of ammonia and amino acids in the blood are measured. Argininosuccinic acid is found to be high in the blood or urine. The diagnosis can be confirmed with a genetic test. In some countries, it is found through newborn screening.
Care is led by a metabolic team. The main approach is a special diet that limits protein. Extra amino acid supplements and treatments that help remove nitrogen are used. If ammonia rises very high, hospital treatment is needed; sometimes blood dialysis is done. A liver transplant may be considered for some people. The blood, liver and blood pressure are checked regularly. Physiotherapy and speech therapy support development. The doctor who follows the disease decides which treatment is suitable.
The disease is passed on through recessive inheritance. The mother and father are usually healthy carriers. For a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. In marriages between relatives, the chance of carrying the same gene is higher. Genetic counselling is recommended for the family.
Source: MedlinePlus Genetics: Argininosuccinic aciduria · NORD: Argininosuccinic Aciduria · Orphanet: Argininosuccinic aciduria (ORPHA:23)
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
For all rare diseases: Nadir Hastalıklar Federasyonu
Links checked on October 8, 2026.
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
ChinaResearch and clinical trials
At a center in Shanghai, 28 patients with ASA followed between 2011 and 2024 were reviewed.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
Questions you can ask your doctor
ClinicalTrials.gov lists 1 active interventional study for this disease. None is recruiting right now; none has a site in Türkiye. Last checked: October 7, 2026.
Selected records (studies with a site in Türkiye first):
Middle stage: the effect is being tested in a small group · Phase 1 / Phase 2 · investigational (experimental)Not yet recruitingNCT07773246
See all studies on ClinicalTrials.gov · Joining clinical trials
EUNew treatments and approvals
In Europe, leriglitazone, taken by mouth, was authorized for cerebral adrenoleukodystrophy.
USANew treatments and approvals
Through the accelerated pathway, the FDA has approved pariglasgene brecaparvovec for glycogen storage disease type Ia.
EuropeResearch and clinical trials
A total of 58 patients from 34 centers in seven European countries were followed.
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:23 · ICD-11 5C50.A0
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.